[The efficacy and safety of siponimod in the Russian population of patients with secondary progressive multiple sclerosis].
Evdoshenko EP, Neofidov NA, Bakhtiyarova KZ, Davydovskaya MV, Kairbekova EI, Kolontareva YM, Malkova NA, Odinak MM, Popova EV, Sazonov DV, Stolyarov ID, Smagina IV, Fedyanin AS, Habirov FA, Khaibullin TI, Khachanova NV, Shchukin IA, Boyko AN.
Evdoshenko EP, et al.
Zh Nevrol Psikhiatr Im S S Korsakova. 2019;119(10. Vyp. 2):110-119. doi: 10.17116/jnevro201911910110.
Zh Nevrol Psikhiatr Im S S Korsakova. 2019.
PMID: 31934996
Clinical Trial.
Russian.